F-15,599

F-15,599 is a psychedelic drug that was first synthesized in the late 20th century. It is a member of the phenethylamine class of compounds and is known for its potent hallucinogenic effects.

History

F-15,599 was first synthesized in the 1990s by a team of chemists led by David E. Nichols at Purdue University. The compound was created as part of a larger project to develop new psychoactive drugs for use in psychiatric research.

Chemistry

F-15,599 is a phenethylamine, a class of compounds that includes many psychoactive drugs. It is structurally related to other psychedelic phenethylamines such as mescaline and 2C-B. The compound is a full agonist at the 5-HT2A receptor, which is thought to be primarily responsible for its hallucinogenic effects.

Effects

The effects of F-15,599 are similar to those of other psychedelic drugs. Users report intense visual hallucinations, altered thought processes, and a heightened sense of empathy. The drug's effects can last for several hours, and are often followed by a period of introspection and afterglow.

Legal status

As of 2021, F-15,599 is not specifically controlled in most countries, but its possession and sale may be illegal under analogue laws. In the United States, for example, it is considered a Schedule I drug under the Federal Analogue Act.

See also

• Psychedelic drug
• Phenethylamine
• David E. Nichols
• Purdue University
• 5-HT2A receptor
• Federal Analogue Act

   This article is a Psychoactive drug-related stub. You can help WikiMD by expanding it!